Epoetin alfa is a medication used in the management of anemia secondary to bone marrow failure. It is one of the erythropoiesis-stimulating classes of drugs. This activity outlines the indications, action, and contraindications of epoetin alfa. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the management of patients with anemia due to bone marrow failure and related conditions.

**Objectives:**
- Describe the importance of epoetin alfa in patients with anemia due to chronic kidney disease and cancer therapy.
- Summarize the risks associated with initiating epoetin alfa along with key patient counseling points to prevent thromboembolism and other side effects.
- Explain the importance of monitoring in the patients who are on epoetin alfa.
- Review the importance of collaboration and coordination among interprofessional team members, which can enhance patient care.